Evidence mapPaperPMID 41609928Full record

ReviewCurrent atherosclerosis reports2026

Pleiotropic Effects of Statins: Focus on Endothelial Function, Plaque Stability and Thrombosis (Part II).

Ali Mahmoudi, Niki Katsiki, Michal Vrablik, Amirhossein Sahebkar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current atherosclerosis reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ali MahmoudiDepartment of Basic Medical Sciences, Faculty of Medicine, Abadan University of Medical Sciences, Abadan, Iran.
Niki KatsikiDepartment of Nutritional Sciences and Dietetics, International Hellenic University, Thessaloniki, 57400, Greece.
Michal VrablikThird Department of Medicine, Department of Endocrinology and Metabolism of the First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Amirhossein SahebkarBiotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. amir_Saheb2000@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewStatins are the first-line therapy for lipid-lowering and cardiovascular (CV) disease (CVD) prevention. Increasing evidence supports additional cardioprotective properties of statins through pleiotropic effects unrelated to lipid modulation. We aimed to discuss the pleiotropic effects of statins and their relevance to clinical outcomes in 2 reviews: Part I focuses on anti-inflammatory, antioxidant and immunomodulatory effects of statins, whereas Part II on statin-induced endothelial function improvement, plaque stabilization and anti-thrombotic effects. Part II also includes a clinical applications and future directions section. RECENT

findingsA literature search was conducted in Embase, Scopus, web of science, PubMed and Cochrane Library databases for experimental and clinical studies investigating the effects of statins on endothelial repair, plaque stability and thrombosis biomarkers. Statins were found to modulate immune cell phenotypes and endothelial repair pathways, as well as enhance plaque stability, inhibit thrombus formation and fibrin clot characteristics independent of lipids. Meta-analyses implicate these pleiotropic actions of statins with reduced CV events. Statins offer cardioprotection through several pleiotropic pathways distinct from lipid-lowering. To maximize clinical benefits, statins’ therapeutic potential beyond CVD should be further explored via non-lipid mechanisms. An in-depth knowledge of statins’ pleiotropic effects may uncover novel preventive strategies and therapeutic applications.

Indexed as

Cardiovascular DiseasesEndothelium, VascularHydroxymethylglutaryl-CoA Reductase InhibitorsPlaque, AtheroscleroticThrombosisAnimalsHumansHydroxymethylglutaryl-CoA Reductase InhibitorsCardiovascular diseaseEndothelial repairPlaque stabilizationPleiotropic effectsStatinsThrombosis

Identifiers

What Socratic holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.